Ledger.Open graph →
SEC Form D · filed March 26, 2021

Scipher Medicine Corp

Offering
$82.0M
Sold
$82.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WALTHAM, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Alif Saleh · Waltham, MAExec · DirectorJeffrey Sachs · Waltham, MAExecAlbert Laszlo Barabasi · Waltham, MADirectorJoseph Loscalzo · Waltham, MADirectorSamir Kaul · Waltham, MADirectorTodd Sone · Waltham, MADirectorMiklos Kobor · Waltham, MADirectorMichael Rubin · Waltham, MADirectorCraig Kasberg · Bellingham, WADirectorDan Rosen · San Francisco, CADirectorAkbar A. Poonawala · NEW YORK, NYExecDavid J. Kemp · Los Gatos, CADirectorNicholas M. Mavris · Los Gatos, CAExec · DirectorDinkar A. Jetley · NEW YORK, NYDirectorMatt Nichols · San Francisco, CADirectorRaman M. Bindlish · Los Gatos, CADirectorAlex R. Klabin · Wellesley, MADirectorMatthew R. Satnick · Wellesley, MADirectorParas Malde · George Town, Grand Cayman, Cayman IslandsDirectorPatrick Agemian · Grand Cayman, Cayman IslandsDirectorMoerus Capital Management LLC · New York, NYExec · DirectorBart Phillips · Edina, MNDirectorJason M. Leverone · Boulder, CODirectorTaras Chumachenko · Moscow, 1ZExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗